DNA methylation markers predict recurrence-free interval in triple-negative breast cancer

We lack tools to risk-stratify triple-negative breast cancer (TNBC). Our goal was to develop molecular tools to predict disease recurrence. Methylation array analysis was performed on 110 samples treated by locoregional therapy obtained from institutional cohorts. Discovered marker sets were then te...

Descripción completa

Detalles Bibliográficos
Autores principales: Fackler, Mary Jo, Cho, Soonweng, Cope, Leslie, Gabrielson, Edward, Visvanathan, Kala, Wilsbach, Kathleen, Meir-Levi, Danielle, Lynch, Charles F., Marks, Jeffrey, Geradts, Joseph, Regan, Meredith M., Viale, Giuseppe, Wolff, Antonio C., Sukumar, Saraswati, Umbricht, Christopher B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994477/
https://www.ncbi.nlm.nih.gov/pubmed/32025567
http://dx.doi.org/10.1038/s41523-020-0145-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994477/
https://www.ncbi.nlm.nih.gov/pubmed/32025567
http://dx.doi.org/10.1038/s41523-020-0145-3

Ejemplares similares